Horizon Discovery Ltd. Sign Commercial Screening Agreement with Silicos NV

August 25, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Horizon Discovery -- Horizon Discovery (Horizon) today announced it has signed a commercial agreement with Belgian computational fragment based drug discovery biotech Silicos NV (Silicos) relating to its X-MAN technology.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Europe